- Home
- BLDE vs OLMA Comparison
BLDE vs OLMA Comparison
Compare BLDE & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- OLMA
- Stock Information
- Founded
- BLDE 2014
- OLMA 2006
- Country
- BLDE United States
- OLMA United States
- Employees
- BLDE N/A
- OLMA N/A
- Industry
- BLDE Aerospace
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- OLMA Health Care
- Exchange
- BLDE Nasdaq
- OLMA Nasdaq
- Market Cap
- BLDE 285.2M
- OLMA 299.7M
- IPO Year
- BLDE N/A
- OLMA 2020
- Fundamental
- Price
- BLDE $3.79
- OLMA $4.61
- Analyst Decision
- BLDE Strong Buy
- OLMA Strong Buy
- Analyst Count
- BLDE 2
- OLMA 4
- Target Price
- BLDE $6.25
- OLMA $24.50
- AVG Volume (30 Days)
- BLDE 789.6K
- OLMA 869.9K
- Earning Date
- BLDE 08-06-2025
- OLMA 08-05-2025
- Dividend Yield
- BLDE N/A
- OLMA N/A
- EPS Growth
- BLDE N/A
- OLMA N/A
- EPS
- BLDE N/A
- OLMA N/A
- Revenue
- BLDE $251,485,000.00
- OLMA N/A
- Revenue This Year
- BLDE $5.58
- OLMA N/A
- Revenue Next Year
- BLDE $8.56
- OLMA N/A
- P/E Ratio
- BLDE N/A
- OLMA N/A
- Revenue Growth
- BLDE 8.67
- OLMA N/A
- 52 Week Low
- BLDE $2.35
- OLMA $2.86
- 52 Week High
- BLDE $5.17
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- BLDE 52.70
- OLMA 56.14
- Support Level
- BLDE $3.57
- OLMA $4.02
- Resistance Level
- BLDE $3.90
- OLMA $4.78
- Average True Range (ATR)
- BLDE 0.20
- OLMA 0.30
- MACD
- BLDE -0.05
- OLMA 0.05
- Stochastic Oscillator
- BLDE 27.91
- OLMA 89.89
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.